|The Value of Active Pharmacy Management: Express Scripts 2018 National Preferred Formulary|
Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/81495241-express-scripts-national-preferred-formulary-2018/
Once an independent panel of medical experts makes its recommendations,
For the 2018 benefit year,
The vast majority of patients we serve – 99.22% to be exact – will not see any changes to their drug coverage. Of course, some patients will be asked to use a different medication that achieves the same health outcome at a lower cost. If any patient has a clinical need that requires a medication that is not on the formulary, we have provided a clear pathway to have that drug covered. Our goal is always to make sure a patient gets the medicine that helps them achieve the best outcome.
Because of our formulary strategies, employers who use the NPF are expected to save an additional
For an example of how the NPF has evolved, you can look at the experience of Tymlos, a new osteoporosis treatment that was launched this year. Tymlos has similar clinical outcomes as the current market-leading drug, Forteo. However, following discussions and negotiations with
Formulary management is one way to bring down drug costs. Throughout the 2000s and on into today, increasing generic utilization has helped lower net drug costs for plan sponsors. That generic wave continues, but is now joined by a "formulary wave," where active pharmacy management can deliver greater value to employers, health plans and other plan sponsors who pay the bulk of the pharmacy bill in
For the first time ever, in 2018, brand drug manufacturers must provide significant savings to be included on the NPF if there are clinically equivalent, lower cost options available. For the 2018 NPF, we focused on high-spend multi-source brand drugs and excluded 46.
|Print | E-mail Page | RSS | Alerts | IR Contacts | Financial Tear Sheet|